Cross-validation of the first trimester screening algorithm of the FMF London on 38 700 pregnancies in Germany;Cross-Validierung des Screening-Algorithmus der FMF London an 38 700 Ersttrimester-Untersuchungen in Deutschland

Ultraschall in der Medizin

Volumn 32, Issue 4, 2011, Pages 367-372

  Luthgens K ^a   Abele, H ^b   Alkier, R ^a   Hoopmann, M ^b   Kagan, K O ^b  

^a Labor Prof Enders und Partner   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

first trimester; nuchal translucency; screening; serum biochemistry

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ALGORITHM; ARTICLE; BLOOD; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETICS; GERMANY; HUMAN; MATERNAL AGE; METABOLISM; METHODOLOGY; NEWBORN; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE; PREGNANCY; PROSPECTIVE STUDY; VALIDATION STUDY;

ADULT; ALGORITHMS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GERMANY; HUMANS; INFANT, NEWBORN; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 79961126641     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-0031-1273348     Document Type: Article

References (23)

1. Nicolaides K H. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004 191 45-67 (Pubitemid 39077955)
2. Kagan K O., Etchegaray A, Zhou Y et al. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009 34 14-18
3. Nicolaides K H., Spencer K, Avgidou K et al. Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005 25 221-226 (Pubitemid 40432687)
4. Eiben B, Thode C, Glaubitz R. Das neue Ersttrimesterscreening-Programm PRC der FMF-Deutschland: erste Erfahrungen zur Trisomie-21-Entdeckungsrate. Frauenarzt 2007 48 2-4
5. Spencer K, Souter V, Tul N et al. A screening program for trisomy 21 at 10 14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999 13 231-237 (Pubitemid 29248329)
6. Lüthgens K. Comparison of the new PRC software with the established algorithm of the FMF UK for the detection of trisomy 21 and 18 / 13. Fetal Diagn Ther 2008 24 376-384
7. Snijders R JM, Noble P, Sebire N et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10 14 weeks of gestation. Lancet 1998 351 343-346 (Pubitemid 28352196)
8. Wright D, Kagan K O., Molina F S. et al. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008 31 376-383
9. Kagan K O., Wright D, Spencer K et al. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008 31 493-502
10. Kagan K O., Frisova V, Nicolaides K H. et al. Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11 13 + 6 weeks of gestation. Prenat Diagn 2007 27 849-853 (Pubitemid 47425405)
11. Cuckle H S., Wald N J., Thompson S G. Estimating a womans risk of having a pregnancy associated with Downs syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987 94 387-402 (Pubitemid 17068086)
12. Snijders R J., Sundberg K, Holzgreve W et al. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999 13 167-170 (Pubitemid 29176889)
13. Spencer K. Accuracy of Down syndrome risks produced in a first trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistry. Prenat Diagn 2002 22 244-246 (Pubitemid 34245842)
14. Kagan K O., Wright D, Baker A et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008 31 618-624
15. Wald N J., Rodeck C, Hackshaw A K. et al. SURUSS in perspective. Semin Perinatol 2005 29 225-235 (Pubitemid 41133562)
16. Logghe H, Cuckle H, Sehmi I. Centre-specific ultrasound nuchal translucency medians needed for Down syndrome screening. Prenat Diagn 2003 23 389-392 (Pubitemid 36596968)
17. Kozlowski P, Knippel A J., Stressig R. Comparing first trimester screening performance: routine care gynaecologists practices vs. prenatal centre. Ultraschall in Med 2007 28 291-295 (Pubitemid 47047587)
18. Abele H, Wagner N, Hoopmann M et al. Effect of deviation from the mid-sagittal planeon the measurement of fetal nuchal translucency. Ultrasound Obstet Gynecol 2010 35 525-529
19. Kagan K O., Wright D, Etchegaray A et al. Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21. Ultrasound Obstet Gynecol 2009 33 657-664
20. Snijders R J., Thom E A., Zachary J M. et al. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002 19 353-359 (Pubitemid 34592131)
21. Palomaki G E., Neveux L M., Donnenfeld A et al. Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective. Genet Med 2008 10 131-138 (Pubitemid 351271725)
22. Koster M P., Wortelboer E J., Engels M A. et al. Quality of nuchal translucency measurements in The Netherlands: a quantitative analysis. Ultrasound Obstet Gynecol 2009 34 136-141
23. Abele H, Hoopmann M, Wright D et al. Intra- and interoperator reliability of manual and semi-automated measurement of fetal nuchal translucency by sonographers with different levels of experience. Ultrasound Obstet Gynecol 2010 36 417-422